Visual and Auditory Complications during Deferasirox Therapy in Beta-thalassemia

نویسندگان
Zeinali, Tahereh ID 1
Baghersalimi, Adel ID 2
Darbandi, Bahram ID 3
Poosheshdoost, Parastoo ID 4
Faraji, Niloofar ID 5
Miremarati, Aye ID 6

1 Gastrointestinal and Liver disease Research Center, Guilan University of Medical science, Rasht, Iran

2 Pediatric Disease Research Center, Guilan University of Medical Science, Rasht, Iran

3 Pediatric Disease Research Center, Guilan University of Medical Science, Rasht, Iran

4 Pediatric Disease Research Center, Guilan University of Medical Science, Rasht, Iran

5 Gastrointestinal and Liver disease Research Center, Guilan University of Medical science, Rasht, Iran

6 Pediatric Disease Research Center, Guilan University of Medical Science, Rasht, Iran

doi
10.18502/ijpho.v12i4.10913
چکیده

Background:  Deferasirox is an oral iron chelator widely used to treat iron overload in patients with transfusion-dependent β-thalassemia. This study investigated the prevalence of visual and auditory complications caused by deferasirox. Materials and Methods: This cross-sectional study included 156 patients aged less than 18 years with transfusion-dependent β-thalassemia and deferasirox ...

کلیدواژه‌ها
Beta-thalassemia, Deferasirox, Hearing loss, Iron chelator, Visual acuity